1019 - Respiratory Syncytial Virus (RSV) Diagnoses in Hospitalized Patients Increases when Additional Specimen Types are Added to Nasopharyngeal Swab: Results from the RSV in Adults Multispecimen Study

Co-Author(s)

• JR

  Julio Ramirez, MD, FACP

  Chief Scientific Officer
  Norton Healthcare
  Louisville, Kentucky, United States

Co-Author(s)

• RC

  Ruth Carrico, PhD, DNP, APRN

  Norton Healthcare
  Louisville, Kentucky, United States
• 

  Ashley M. Wilde, PharmD, BCIDP

  Director, Infectious Diseases Clinical Program and Research
  Norton Healthcare
  Louisville, Kentucky, United States
• AJ

  Alan Junkins, PhD, D(ABMM)

  Chief of Microbiology
  Norton Healthcare
  Louisville, Kentucky, United States
• TC

  Thomas R. Chandler, MPH

  Biostatistician
  Norton Healthcare
  Louisville, Kentucky, United States
• SF

  Stephen Furmanek, MPH, MS

  Senior Biostatistician
  Norton Healthcare
  Louisville, Kentucky, United States
• RH

  Robin Hubler, MS

  Pfizer Inc.
  Collegeville, Pennsylvania, United States
• QL

  Qing Liu, M.S.

  Pfizer Inc.
  Collegeville, Pennsylvania, United States
• SU

  Sonal Uppal, Ph.D.

  Clinical Scientist - Senior Manager
  Pfizer
  Champaign, Illinois, United States
• PP

  Paula Peyrani, MD

  Senior Director
  Pfizer, Inc
  Collegeville, Pennsylvania, United States
• NA

  Negar Aliabadi, MD, MS

  Pfizer
  New York, New York, United States
• BG

  Bradford J. Gessner, M.D., M.P.H.

  Vice President Global Medical Lead for Respiratory Vaccines
  Pfizer Biopharma Group
  Collegeville, Pennsylvania, United States

Presenting Author(s)

• 

  Elizabeth Begier, MD, M.P.H.

  Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
  Pfizer Vaccines
  Dublin, Dublin, Ireland

  Slides